Abstract
Purpose of Review
Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We performed a systematic review to obtain a clearer picture of the epidemiology of psoriasis and psoriatic arthritis across and within specific regions of Italy.
Recent Findings
Prevalence of psoriasis in specific regions showed more variability (0.8–4.5%) than that in the total population (1.8–3.1%). Prevalence of psoriatic arthritis in the general population was reported for only two regions, Chiavari (0.09%) and Marche (0.42%). All other studies reported prevalence of psoriatic arthritis in patients with psoriasis in single centres and Italy-wide (4.7–47.1%). Prevalence of psoriatic arthritis was highest in patients with nail and/or scalp psoriasis and/or intergluteal/perianal region involvement.
Summary
Based on current available data, these conditions appear to affect a substantial number of people and will likely have an important impact on the Italian healthcare system.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• World Health Organization. Global report on psoriasis. 2016. Available at http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf. Accessed 09 Aug 2017. This report provides an extensive global overview of psoriasis and the burden and impact on quality of life of psoriasis.
Cimmino MA. Epidemiology of psoriasis and psoriatic arthritis. Reumatismo. 2007;59(Suppl 1):19–24.
Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(5):871–81.e1–30.
Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012;7:e52935.
Christophers E, Barker JN, Griffiths CE, Daudén E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548–54.
Patrizi A, Venturi M, Scorzoni R, Pazzaglia M, Malavolta N, Bardazzi F. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol. 2014;149(2):177–84.
Bonifati C, Elia F, Francesconi F, Ceralli F, Izzi S, Solivetti FM, et al. The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis. J Eur Acad Dermatol Venereol. 2012;26(5):627–33.
Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol. 2005;15(4):279–83.
Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010;20(5):593–8.
Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol. 2010;39:310–7.
Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
De Angelis R, Salaffi F, Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007;36(1):14–21.
Salaffi F, De Angelis R, Grassi W, MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23(6):819–28.
Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One. 2012;7(3):e32487.
Saraceno R, Mannheimer R, Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol. 2008;22(3):324–9.
Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C, et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology. 2004;208(1):38–42.
Cimmino MA, Zampogna A, Murroni S, Baruffi S, Alessio G, Maio T, et al. Methodology of an epidemiologic prevalence study in rheumatology: the Chiavari study [in Italian]. Reumatismo. 2002;54(1):40–7.
• Dini V, Martini P, Bellini M, Bagnoni G, Marsili F, Lancia U. Psoriatic arthritis prevalence in the clinical practice of dermatologists in North-West Tuscany centres of excellence for psoriasis: a screening experience. G Ital Dermatol Venereol. 2017;152:24–7. This study provides insights into the presentation of arthritis in patients with psoriasis and differences between patients with psoriasis with and without arthritis in a clinical setting.
• Piaserico S, Gisondi P, Amerio P, Amoruso G, Campanati A, Conti A, et al. Validation and field performance of the Italian version of the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire. Acta Derm Venereol. 2016;96(217):96–101. This study validates the Italian version of the Psoriatic Arthritis Screening and Evaluation questionnaire in a real-world setting across multiple dermatology clinics in Italy.
De Marco G, Cattaneo A, Battafarano N, Lubrano E, Carrera CG, Marchesoni A. Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. Arch Dermatol Res. 2012;304(9):719–26.
Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, et al. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health. 2007;7:59.
Finzi AF, Benelli C. A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis. J Eur Acad Dermatol Venereol. 1998;10(2):125–9.
Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W, et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol. 1995;22(8):1499–503.
De Marco G, Cattaneo A, Carrera CG, Gibertini P, Battafarano N, Marchesoni A. The EPIPSOFIRE project: a preliminary report. Drug Dev Res. 2014;75(Suppl 1):S85–7.
Tinazzi I, Adami S, Zanolin EM, Caimmi C, Confente S, Girolomoni G, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford). 2012;51(11):2058–63.
Cervini C, Leardini G, Mathieu A, Punzi L, Scarpa R. Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients [in Italian]. Reumatismo. 2005;57(4):283–90.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.
Acknowledgments
The authors would like to acknowledge Caroline Spencer and Dr Sue Chambers (Rx Communications, Mold, UK) for medical writing assistance with the preparation of this manuscript, funded by Eli Lilly and Company.
Funding
This work was funded by Eli Lilly and Company.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Veronica Rogai, Elisabetta Cavallucci and Alessandro Bitossi are employees and shareholders of Eli Lilly and Company. Volker Hammen is a former employee of Eli Lilly and Company. Fabrizio Cantini is a member of advisory boards for Eli Lilly. Francesca Prignano is a member of advisory boards and/or speaker for Eli Lilly, Abiogen Pharma, Abbvie, Novartis, Pfizer and Leo Pharma.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Psoriatic Arthritis
Rights and permissions
About this article
Cite this article
Prignano, F., Rogai, V., Cavallucci, E. et al. Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review. Curr Rheumatol Rep 20, 43 (2018). https://doi.org/10.1007/s11926-018-0753-1
Published:
DOI: https://doi.org/10.1007/s11926-018-0753-1